ENDOMETRIOSIS FOUNDATION OF AMERIC… - Form 990 Financial Data

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

2006

Legal Domicile

Principal Officer

TAMER SECKIN MD

Phone

2129881644

Tax Period

2024-01-01 to 2024-12-31

ENDOMETRIOSIS FOUNDATION OF AMERICA INC, founded in 2006, is a community nonprofit in the Philanthropy & Grantmaking sector that reported $1.9M in total revenue in fiscal year 2024. Expenses of $1.8M left a modest 8% surplus.

Mission

THE ENDOMETRIOSIS FOUNDATION OF AMERICA (ENDOFOUND) STRIVES TO INCREASE DISEASE RECOGNITION, PROVIDE ADVOCACY, FACILITATE EXPERT SURGICAL TRAINING, AND FUND LANDMARK ENDOMETRIOSIS RESEARCH. ENGAGED IN A ROBUST CAMPAIGN TO INFORM BOTH THE MEDICAL COMMUNITY AND THE PUBLIC, ENDOFOUND PLACES PARTICULAR EMPHASIS ON THE CRITICAL IMPORTANCE OF EARLY DIAGNOSIS AND EFFECTIVE INTERVENTION WHILE SIMULTANEOUSLY PROVIDING EDUCATION TO THE NEXT GENERATION OF MEDICAL PROFESSIONALS AND THEIR PATIENTS.

Program Service Accomplishments

Program 1

Expenses: $1,136,046

THE ENDOFOUND EDUCATION PROGRAM IS A SCHOOL AND COMMUNITY-BASED EDUCATION PROGRAM DESIGNED TO EDUCATE HIGH SCHOOL STUDENTS AND RAISE AWARENESS ABOUT ENDOMETRIOSIS THROUGH AN INTERACTIVE PROGRAM WHICH INCLUDES BOTH EDUCATION OF THE DISEASE AND TO TEACH STUDENTS HOW TO ADVOCATE FOR THEMSELVES. TO DATE, THE PROGRAM HAS EDUCATED 40,000 STUDENTS IN THE US AND ABROAD.

Program 2

Expenses: $237,849

CONFERENCES AND WEBINARS: HISTORICALLY ENDOFOUND RUNS TWO LARGE ANNUAL CONFERENCES. THE FIRST IS A MEDICAL CONFERENCE WHICH GATHERS PHYSICIANS, SURGEONS, RESEARCHERS, NURSES, FROM ALL OVER THE WORLD TO LEARN ABOUT CURRENT TRENDS AND BEST PRACTICES FOR THE TREATMENT OF ENDOMETRIOSIS. THE SECOND IS A PATIENT CONFERENCE BRINGING PATIENTS AND PHYSICIANS TOGETHER TO LEARN IN DEPTH ABOUT ENDOMETRIOSIS, MANAGEMENT OF THE DISEASE, SUPPORT AVAILABLE AND WELLNESS TRAINING.

Program 3

Expenses: $84,700

RESEARCH AND GRANTS - ENDOFOUND FUNDS CUTTING-EDGE MEDICAL RESEARCH AT MEDICAL INSTITUTIONS AND HOSPITALS IN THE US PREDOMINANTLY, AND IN OTHER COUNTRIES. RESEARCH IS CONDUCTED ON THE ETIOLOGY OF THE DISEASE, GENETIC IMPLICATIONS, AND ORGANS AFFECTED BY THE DISEASE, AMONG OTHERS, ALL WITH THE GOAL OF DEVELOPING BETTER DIAGNOSTICS AND BETTER TREATMENTS.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2024)

Revenue Breakdown

Contributions & Grants $1,895,490

Program Service Revenue $0

Investment Income $34,957

Other Revenue $0

TOTAL REVENUE $1,930,447

Expense Breakdown

Grants Paid $75,000

Salaries & Benefits $417,123

Fundraising Expenses $175,570

Program Expenses $1,458,595

Other Expenses $1,291,250

TOTAL EXPENSES $1,783,373

Year-over-Year Comparison

	2024	2023	Change
Revenue	$1,930,447	$1,905,569	+0.0%
Expenses	$1,783,373	$1,532,820	+0.2%
Net Income	$147,074	$372,749	-0.6%

Key Indicators

✓ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

Volunteers

Governance Policies

✓ Conflict of Interest Policy

✓ Whistleblower Policy

✓ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

⚠ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
TAMER SECKIN MD	PRESIDENT	5.00	Officer Director	$0	$0	$0
ELIF SECKIN	TREASURER	2.00	Officer Director	$0	$0	$0
PIRAYE YURTTAS BEIM PHD	DIRECTOR	2.00	Director	$0	$0	$0
LAWRENCE LIVORNESE	DIRECTOR	2.00	Director	$0	$0	$0
HARRY REICH MD	DIRECTOR	2.00	Director	$0	$0	$0
MADELEINE K RUDIN	DIRECTOR	2.00	Director	$0	$0	$0
KRISTY CURRY	DIRECTOR	2.00	Director	$0	$0	$0
KARLI GOLDSTEIN DO	DIRECTOR (THROUGH 6/24)	2.00	Director	$0	$0	$0
MICHAEL S BRODHERSON MD	DIRECTOR (THROUGH 5/24)	2.00	Director	$0	$0	$0
CAROLYN MAYER	SENIOR PROGRAM MANAGER	40.00	Highest	$125,000	$13,203	$138,203
CAROLYNN RICCI	CHIEF DEVELOPMENT OFFICER	40.00	Highest	$102,273	$9,570	$111,843

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2024	$1,930,447	$1,783,373	$2,836,213	$147,074
2023	$1,905,569	$1,532,820	$2,671,890	$372,749
2022	$1,302,317	$1,120,272	$2,270,980	$182,045
2022	$1,527,339	$1,097,794	$2,270,980	$429,545
2021	$1,893,554	$1,142,579	$2,157,273	$750,975
2020	$1,078,238	$991,421	$1,381,269	$86,817

ENDOMETRIOSIS FOUNDATION OF AMERICA INC